Featured Researchers

Dr. John Bell


 
Thanks to the dedication and enthusiasm of Mo Bros and Mo Sistas across the country, funds raised through Movember enable Prostate Cancer Canada to select and support research that will make a big difference in the lives of everyone affected by the most common cancer in men. A recent example of this us research being undertaken by Dr. John Bell of the University of Ottawa in the area of immunotherapy. More specifically, he and a team of researchers from a number of institutions across the country are engineering cancer-killing viruses. It is your moustaches and MOVEs that continue to make life-changing work possible. Please check out the video to learn more about the difference you're making!


Dr. Paul Boutros

 

To mark Prostate Cancer Awareness Month, we wanted to highlight some of the great research taking place that has been made possible through the generosity of Canadians like the work being led by Dr. Paul Boutros. Together, we are making a difference in the lives of the 1 in 8 Canadian men who will be diagnosed with prostate cancer and their families.


Dr. Paul Rennie & Dr. Artem Cherkasov

 

Drs. Paul Rennie and Artem Cherkasov of the Vancouver Prostate Centre, who are developing an effective drug for men who have become resistant to treatment, acknowledge the importance of Prostate Cancer Canada and its supporters in making their ground-breaking work possible.


Dr. Gang Zheng

 
 

Prostate Cancer Canada funded researcher Dr. Gang Zheng has discovered a "smart" organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.

For more information and support:

 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More

Scientists identify DNA signature linked to prostate cancer severity

January 9, 2017 – TORONTO, ON – The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature.
More

Thank You to our Canadian Mo Bros and Sistas!

TORONTO, December 1, 2016 - Prostate Cancer Canada congratulates the more than 500,000 Mo Bros and Mo Sistas worldwide who participated in this year's Movember campaign.
More


Click here for news archive